You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gemtuzumab

Showing 51 - 75 of 112
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Acute Myeloid Leukemia Included inPatient

Unknown status
  • Leukemia, Myeloid, Acute
  • Gemtuzumab Ozogamicin (GO)
  • Amiens, France
  • +10 more
Jan 23, 2018

Multicenter Retrospective Observatory of Acute Myeloid Leukemia

Recruiting
  • Acute Myeloblastic Leukemia Core Binding Factor
  • NOT PROVIDED
  • Amiens, France
  • +25 more
Sep 27, 2021

Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • Acute Promyelocytic Leukemia
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

AML, Adult, MDS Trial in Lørenskog (Standard therapy, Precision therapy)

Recruiting
  • AML, Adult
  • MDS
  • Standard therapy
  • Precision therapy
  • Lørenskog, Norway
    Akershus Universitetssykehus
Aug 23, 2021

Ovarian Cancer, Endometrial Cancer Trial in Shanghai (Arsenic trioxide for injection)

Recruiting
  • Ovarian Cancer
  • Endometrial Cancer
  • Arsenic trioxide for injection
  • Shanghai, Shanghai, China
    Shanghai JiaoTong University School of Medicine affliated Ruijin
Jul 25, 2020

CD33 Positive Acute Myelogenous Leukemia Trial in United States (Antibody Drug Conjugate Chemotherapeutic)

No longer available
  • CD33 Positive Acute Myelogenous Leukemia
  • Antibody Drug Conjugate Chemotherapeutic
  • Birmingham, Alabama
  • +141 more
Aug 17, 2019

Acute Myeloid Leukaemia, Myelodysplastic Syndrome Trial in Denmark, United Kingdom (Arm A Mylotarg plus DA Versus CPX-351, Arm B

Unknown status
  • Acute Myeloid Leukaemia
  • Myelodysplastic Syndrome
  • Arm A Mylotarg plus DA Versus CPX-351
  • +5 more
  • Aalborg, Denmark
  • +86 more
Jan 22, 2020

Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapse Trial in

Unknown status
  • Acute Lymphoblastic Leukemia Recurrent
  • +4 more
  • INA03 administration
  • Marseille, Bouches-du Rhône, France
  • +1 more
Feb 4, 2020

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
Has Results
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • gemtuzumab ozogamicin
  • +2 more
  • Stanford, California
  • +3 more
May 30, 2017

Leukemia Trial in Houston (Mylotarg)

Terminated
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

Acute Myeloid Leukemia Trial in France (gemtuzumab ozogamycin)

Completed
  • Acute Myeloid Leukemia
  • gemtuzumab ozogamycin
  • Aix, France
  • +28 more
Jan 26, 2017

Leukemia, MDS Trial in United Kingdom (cytarabine, daunorubicin HCl, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Basingstoke, England, United Kingdom
  • +5 more
Sep 19, 2016

DNA Samples From Acute Myeloid Leukemia Treated on COG-AAML0531

Completed
  • Leukemia
  • DNA analysis
  • +3 more
  • (no location specified)
May 17, 2016

Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in United States (Cytarabine,

Completed
Has Results
  • Chronic Myelomonocytic Leukemia-2
  • +3 more
  • Bozeman, Montana
  • +8 more
Apr 11, 2018

DNA Samples From Younger Newly Diagnosed Acute Myeloid Leukemia

Completed
  • Leukemia
  • DNA analysis
  • +3 more
  • (no location specified)
May 17, 2016

Acute Myeloid Leukemia Trial in Aarhus, Copenhagen (Gemtuzumab ozogamicin)

Completed
  • Acute Myeloid Leukemia
  • Gemtuzumab ozogamicin
  • Aarhus, Denmark
  • +1 more
May 12, 2016

Acute Myeloid Leukemia Trial in Pittsburgh (Gemtuzumab ozogamicin, Mitoxantrone, Etoposide)

Terminated
  • Acute Myeloid Leukemia
  • Gemtuzumab ozogamicin
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute / Hillman Cancer Cente
Jan 14, 2016

Leukemia Trial in Puerto Rico, United States (ara-C, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Anniston, Alabama
  • +77 more
Jul 12, 2016

Leukemia Trial in Chapel Hill (clofarabine, gemtuzumab ozogamicin)

Terminated
  • Leukemia
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Oct 7, 2015

Leukemia, MDS Trial in Cleveland (arsenic trioxide, gemtuzumab ozogamicin)

Completed
Has Results
  • Leukemia
  • Myelodysplastic Syndromes
  • arsenic trioxide
  • gemtuzumab ozogamicin
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center
Jul 6, 2015

Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in New York City (Gemtuzumab

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Gemtuzumab Ozogamicin
  • +6 more
  • New York City, New York
    Morgan Stanley Children's Hospital of NYP
Apr 20, 2015

S9031-9333-0106-0112-A Study of Biomarkers in Samples From Acute

Completed
  • Leukemia
  • DNA analysis
  • +5 more
  • (no location specified)
Mar 5, 2015

Leukemia Trial in Canada, Sweden, United States (gemtuzumab ozogamicin, observation, Cytosine arabinoside)

Completed
Has Results
  • Leukemia
  • gemtuzumab ozogamicin
  • +3 more
  • Anchorage, Alaska
  • +278 more
Sep 25, 2015

Leukemia, AML, MDS Trial in Houston (Cytarabine, Fludarabine)

Completed
Has Results
  • Leukemia
  • +3 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Feb 17, 2016

Leukemia Trial in United States (cytarabine, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Berkeley, California
  • +150 more
Mar 5, 2015